Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Braden Manns

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Annals of Internal Medicine|April 25, 2009
ACP Journal Club. Review: Brand-name drugs are not more effective than generic versions for treating cardiovascular diseaseBraden Manns
Evidence-Based Medicine|June 2, 2009
Review: brand-name drugs are not more effective than generic versions for treating cardiovascular diseaseBraden Manns
Circulation|October 26, 2018
Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney DiseaseMatthew James, Braden Manns
JAMA|April 13, 2011
Supplementing creatinine-based estimates of risk in chronic kidney disease: is it time?Marcello Tonelli, Braden Manns
ACP Journal Club|May 2, 2006
Oral mycophenolate led to more complete remissions than intravenous cyclophosphamide for active lupus nephritisMike Walsh, Braden Manns
Clinical Journal of the American Society of Nephrology : CJASN|April 26, 2014
Do socioeconomic factors affect dialysis modality selection?Gihad Nesrallah, Braden Manns
Seminars in Nephrology|September 16, 2009
Economic evaluation of dialysis therapiesScott Klarenbach, Braden Manns
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2008
Optimizing the use of prescription drugs in Canada through the Common Drug ReviewMike Tierney, Braden Manns,
ACP Journal Club|November 4, 2006
N-acetylcysteine prevented contrast-medium-induced nephropathy in primary angioplastyMatthew James, Braden Manns
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2002
Costing health care procedures: art or science?Gillian R Currie, Braden Manns
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Annals of Internal Medicine|April 25, 2009
ACP Journal Club. Review: Brand-name drugs are not more effective than generic versions for treating cardiovascular diseaseBraden Manns
Evidence-Based Medicine|June 2, 2009
Review: brand-name drugs are not more effective than generic versions for treating cardiovascular diseaseBraden Manns
Circulation|October 26, 2018
Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney DiseaseMatthew James, Braden Manns
JAMA|April 13, 2011
Supplementing creatinine-based estimates of risk in chronic kidney disease: is it time?Marcello Tonelli, Braden Manns
ACP Journal Club|May 2, 2006
Oral mycophenolate led to more complete remissions than intravenous cyclophosphamide for active lupus nephritisMike Walsh, Braden Manns
Clinical Journal of the American Society of Nephrology : CJASN|April 26, 2014
Do socioeconomic factors affect dialysis modality selection?Gihad Nesrallah, Braden Manns
Seminars in Nephrology|September 16, 2009
Economic evaluation of dialysis therapiesScott Klarenbach, Braden Manns
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2008
Optimizing the use of prescription drugs in Canada through the Common Drug ReviewMike Tierney, Braden Manns,
ACP Journal Club|November 4, 2006
N-acetylcysteine prevented contrast-medium-induced nephropathy in primary angioplastyMatthew James, Braden Manns
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2002
Costing health care procedures: art or science?Gillian R Currie, Braden Manns
Pageof 23